As of 2025-10-19, the Intrinsic Value of Rapt Therapeutics Inc (RAPT) is -32.19 USD. This RAPT valuation is based on the model Peter Lynch Fair Value. With the current market price of 29.34 USD, the upside of Rapt Therapeutics Inc is -209.72%.
Based on its market price of 29.34 USD and our intrinsic valuation, Rapt Therapeutics Inc (RAPT) is overvalued by 209.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -32.19 - -32.19 | -32.19 | -209.72% |
| P/E | (43.78) - (73.27) | (55.53) | -289.3% |
| DDM - Stable | (34.49) - (97.59) | (66.04) | -325.1% |
| DDM - Multi | (8.29) - (18.87) | (11.58) | -139.5% |
| Market Cap (mil) | 485.28 |
| Beta | 1.89 |
| Outstanding shares (mil) | 16.54 |
| Enterprise Value (mil) | 443.40 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.50% |
| Cost of Debt | 5.00% |
| WACC | 8.59% |